Sanara MedTech is a medical technology company that develops and commercializes surgical wound care and bone fusion products designed to improve clinical outcomes and reduce healthcare costs. The company sells soft tissue repair solutions—including its lead product CellerateRX Surgical, a hydrolyzed collagen powder, along with antimicrobial irrigation solutions and tissue matrices—and bone fusion implants to surgeons at hospitals and ambulatory surgical centers across the United States through a network of surgical specialty distributors and in-house sales representatives. The company generates revenue from direct product sales to operating rooms as sterile consumables without reimbursement risk, outsourcing manufacturing to contract manufacturers while maintaining proprietary relationships, including exclusive licensing rights for collagen peptide technologies.